Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)
Clinical trial NCT01031537 · TERMINATED
Trial details
- NCT number
- NCT01031537
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-25
- Primary completion
- 2016-12-23
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.